(0.08%) 5 250.25 points
(0.04%) 39 656 points
(0.13%) 18 280 points
(0.41%) $78.58
(1.24%) $2.28
(-0.90%) $2 353.60
(-0.49%) $28.37
(0.13%) $1 008.50
(-0.05%) $0.928
(0.18%) $10.85
(0.02%) $0.799
(-0.97%) $91.77
Quarter results tomorrow
(amc 2024-05-14)
Expected move: +/- 9.70%
Live Chart Being Loaded With Signals
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States...
Stats | |
---|---|
Today's Volume | 233 859 |
Average Volume | 669 300 |
Market Cap | 31.23M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.0600 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.890 |
ATR14 | $0.00100 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Fair John A | Buy | 290 000 | Employee Stock Option (right to buy) |
2024-03-12 | Johnson Sabrina Martucci | Buy | 750 000 | Employee Stock Option (right to buy) |
2024-03-12 | Haring-layton Mardee | Buy | 290 000 | Employee Stock Option (right to buy) |
2024-01-26 | Haring-layton Mardee | Sell | 3 500 | Employee Stock Option (right to buy) |
2024-01-26 | Haring-layton Mardee | Sell | 30 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
78.51 |
Last 91 transactions |
Buy: 10 072 923 | Sell: 492 500 |
Volume Correlation
Dare Bioscience Inc Correlation
10 Most Positive Correlations | |
---|---|
PRPO | 0.884 |
BCDA | 0.881 |
UCL | 0.875 |
SNDL | 0.872 |
AQB | 0.872 |
JOAN | 0.87 |
POTX | 0.87 |
AQMS | 0.87 |
STAF | 0.87 |
BLNK | 0.868 |
10 Most Negative Correlations | |
---|---|
LEDS | -0.902 |
MPRA | -0.871 |
MTEK | -0.865 |
OBNK | -0.861 |
PUCKU | -0.841 |
MTEM | -0.838 |
BWMX | -0.836 |
NCAC | -0.834 |
MTCR | -0.832 |
CCRC | -0.83 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dare Bioscience Inc Correlation - Currency/Commodity
Dare Bioscience Inc Financials
Annual | 2023 |
Revenue: | $2.81M |
Gross Profit: | $2.77M (98.63 %) |
EPS: | $-0.350 |
FY | 2023 |
Revenue: | $2.81M |
Gross Profit: | $2.77M (98.63 %) |
EPS: | $-0.350 |
FY | 2022 |
Revenue: | $10.00M |
Gross Profit: | $9.95M (99.52 %) |
EPS: | $4.81 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.630 |
Financial Reports:
No articles found.
Dare Bioscience Inc
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators